Cover Image
市場調查報告書

Aileron Therapeutics, Inc.:產品平台分析

Aileron Therapeutics, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 314854
出版日期 內容資訊 英文 26 Pages
訂單完成後即時交付
價格
Back to Top
Aileron Therapeutics, Inc.:產品平台分析 Aileron Therapeutics, Inc. - Product Pipeline Review - 2015
出版日期: 2015年04月15日 內容資訊: 英文 26 Pages
簡介

Aileron Therapeutics, Inc. 是開發及產品化勝肽的生物製藥公司,提供癌症和感染疾病、代謝障礙、內分泌障礙、免疫及發炎性疾病等治療藥。

本報告提供Aileron Therapeutics, Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Aileron Therapeutics, Inc.的基本資料

  • Aileron Therapeutics, Inc.概要
  • 主要資訊
  • 企業資料

Aileron Therapeutics, Inc.:R&D概要

  • 主要的治療範圍

Aileron Therapeutics, Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Aileron Therapeutics, Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

Aileron Therapeutics, Inc.:藥物簡介

  • ALRN-5281
  • ALRN-6924
  • ATSP-7041
  • ATSP-9172

Aileron Therapeutics, Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Aileron Therapeutics, Inc.:最近的開發平台趨勢

Aileron Therapeutics, Inc.:暫停中的計劃

Aileron Therapeutics, Inc.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06939CDB

Summary

Global Markets Direct's, 'Aileron Therapeutics, Inc. - Product Pipeline Review - 2015', provides an overview of the Aileron Therapeutics, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Aileron Therapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Aileron Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Aileron Therapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Aileron Therapeutics, Inc.'s pipeline products

Reasons to buy

  • Evaluate Aileron Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Aileron Therapeutics, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Aileron Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Aileron Therapeutics, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Aileron Therapeutics, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Aileron Therapeutics, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Aileron Therapeutics, Inc. Snapshot
    • Aileron Therapeutics, Inc. Overview
    • Key Information
    • Key Facts
  • Aileron Therapeutics, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Aileron Therapeutics, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Aileron Therapeutics, Inc. - Pipeline Products Glance
    • Aileron Therapeutics, Inc. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Aileron Therapeutics, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Aileron Therapeutics, Inc. - Drug Profiles
    • ALRN-6924
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ALRN-5281
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ATSP-7041
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ATSP-9172
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Aileron Therapeutics, Inc. - Pipeline Analysis
    • Aileron Therapeutics, Inc. - Pipeline Products by Target
    • Aileron Therapeutics, Inc. - Pipeline Products by Route of Administration
    • Aileron Therapeutics, Inc. - Pipeline Products by Molecule Type
    • Aileron Therapeutics, Inc. - Pipeline Products by Mechanism of Action
  • Aileron Therapeutics, Inc. - Recent Pipeline Updates
  • Aileron Therapeutics, Inc. - Dormant Projects
  • Aileron Therapeutics, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Aileron Therapeutics, Inc., Key Information
  • Aileron Therapeutics, Inc., Key Facts
  • Aileron Therapeutics, Inc. - Pipeline by Indication, 2015
  • Aileron Therapeutics, Inc. - Pipeline by Stage of Development, 2015
  • Aileron Therapeutics, Inc. - Monotherapy Products in Pipeline, 2015
  • Aileron Therapeutics, Inc. - Phase I, 2015
  • Aileron Therapeutics, Inc. - Preclinical, 2015
  • Aileron Therapeutics, Inc. - Pipeline by Target, 2015
  • Aileron Therapeutics, Inc. - Pipeline by Route of Administration, 2015
  • Aileron Therapeutics, Inc. - Pipeline by Molecule Type, 2015
  • Aileron Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2015
  • Aileron Therapeutics, Inc. - Recent Pipeline Updates, 2015
  • Aileron Therapeutics, Inc. - Dormant Developmental Projects,2015

List of Figures

  • Aileron Therapeutics, Inc. - Pipeline by Top 10 Indication, 2015
  • Aileron Therapeutics, Inc. - Pipeline by Stage of Development, 2015
  • Aileron Therapeutics, Inc. - Monotherapy Products in Pipeline, 2015
  • Aileron Therapeutics, Inc. - Pipeline by Top 10 Target, 2015
  • Aileron Therapeutics, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Aileron Therapeutics, Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Aileron Therapeutics, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top